Real‐world data on efficacy/safety and economic impact of nivolumab administered every 2 and 4 weeks among Japanese patients. - Tasaki, Yoshihiko; Ito, Nanami; Mimura, Yoshihisa; Sugiyama, Yosuke; Ogawa, Ryo; Shimura, Takaya; Nakamura, Motoki; Kawakita, Daisuke; Hamamoto, Shuzo; Uemura, Takehiro; Yokota, Keisuke; Iida, Moeko; et al. (Asia Pacific Journal of Clinical Oncology, 2024)